FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

12134611000001104: Stugeron 15mg tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
43794701000001118 Stugeron 15mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43794801000001110 Stugeron 15mg tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Is a Product containing precisely cinnarizine 15 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has active ingredient Cinnarizine false Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Is a Stugeron true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Cinnarizine true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Stugeron 15mg tablets (Janssen-Cilag Ltd) 100 tablet 10 x 10 tablets Is pack of False Stugeron 15mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Stugeron 15mg tablets (Janssen-Cilag Ltd) 100 tablet 10 x 10 tablets Has AMP True Stugeron 15mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start